Skip to main content
. 2011 Aug 1;2:31. doi: 10.3389/fimmu.2011.00031

Figure 2.

Figure 2

Alternative DC licensing for cross-priming is mediated by NKT cells recognizing glycolipid antigens. DCs interact with NKT cells via glycolipid antigen that is presented on CD1d and recognized by an invariant TCR. Moreover, CD40–CD40L interactions lead to an upregulation of costimulatory molecules for CTL cross-priming.